Coronavirus News Roundup: Pharmacists Authorized to Administer COVID-19 Vaccines, MJH Life Sciences to Host Webinar on Dual Flu, COVID-19 Threats

Article

Here's this week's coronavirus-related news you should know.

COVID-19 vaccine

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 24,495,232 individuals worldwide, and approximately 5.9 million Americans. The latest COVID-19 related news includes the Department of Health and Human Services (HHS) permitting pharmacists to order and administer COVID-19 vaccines and MJH Life Sciences™ hosting an upcoming webinar concerning the convergence of flu season and SARS-CoV-2 infections.

Here’s a roundup of the latest coronavirus-related news:

MJH Life Sciences COVID-19 Coalition to Host Live Webinar on Dual Flu, COVID-19 Threats

To kick off its partnership with top health care experts, the newly launched MJH Life Sciences™ COVID-19 Coalition will host its inaugural webinar event exploring dual threats as flu season and COVID-19 converge.

"Battling Dual Threats: Flu and COVID-19 Converge," a free, live, 1-hour webinar, will be broadcasted on Tuesday, September 15, at 6 p.m. EDT.

Read more

Oncology Pharmacists Adapt to Serve Patients Amid Pandemic

The COVID-19 pandemic has undeniably placed a significant burden on patients with cancer receiving chemotherapy and other medications and services.

However, oncology pharmacists quickly adapted, learning new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens.

Read more

HHS Permits Pharmacists to Order and Administer COVID-19 Vaccines

HHS has authorized state-licensed pharmacists to order and administer, and state-licensed or registered pharmacy interns under the supervision of the pharmacist to administer, COVID-19 vaccines to individuals ages 3 or older, according to an announcement.

Read more

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.